Marta Sanchez-Carbayo
Overview
Explore the profile of Marta Sanchez-Carbayo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
2879
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Filella X, Gonzalez A, Auge J, Barco A, Carbonell R, Gaspar M, et al.
Adv Lab Med
. 2023 Dec;
4(3):207-211.
PMID: 38075179
Prostate cancer screening based on prostate-specific antigen (PSA) testing has been a matter of controversy. Although screening for prostate cancer was effective in reducing mortality, it resulted in overdiagnosis, which...
2.
Filella X, Gonzalez A, Auge J, Barco A, Carbonell R, Gaspar M, et al.
Adv Lab Med
. 2023 Dec;
4(3):212-217.
PMID: 38075164
No abstract available.
3.
Clausen T, Kumar G, Ibsen E, Orum-Madsen M, Hurtado-Coll A, Gustavsson T, et al.
Cell Death Discov
. 2020 Aug;
6:65.
PMID: 32793395
Proteoglycans in bladder tumors are modified with a distinct oncofetal chondroitin sulfate (ofCS) glycosaminoglycan that is normally restricted to placental trophoblast cells. This ofCS-modification can be detected in bladder tumors...
4.
Bermudez-Oria A, Rodriguez-Gutierrez G, Rubio-Senent F, Sanchez-Carbayo M, Fernandez-Bolanos J
J Med Food
. 2020 Jan;
23(7):719-727.
PMID: 31939715
Bladder cancer (BC) is one of the most common human cancers. There is an interest in controlling and treating BC and other types of cancer via the use of natural...
5.
Costa-Machado L, Martin-Hernandez R, Sanchez-Luengo M, Hess K, Vales-Villamarin C, Barradas M, et al.
EMBO Rep
. 2018 Jul;
19(9).
PMID: 30021836
The NAD-dependent deacetylase SIRT1 can be oncogenic or tumor suppressive depending on the tissue. Little is known about the role of SIRT1 in non-small cell lung carcinoma (NSCLC), one of...
6.
Zuiverloon T, van Kessel K, Bivalacqua T, Boormans J, Ecke T, Grivas P, et al.
Urol Oncol
. 2018 Mar;
36(9):423-431.
PMID: 29496372
Rationale: Several guidelines exist that address treatment of patients with nonmetastatic muscle-invasive bladder cancer (MIBC). However, most only briefly mention follow-up strategies for patients and hence the treating physician is...
7.
de Opakua A, Merino N, Villate M, Cordeiro T, Ormaza G, Sanchez-Carbayo M, et al.
PLoS One
. 2017 Feb;
12(2):e0172507.
PMID: 28207895
The metastasis suppressor KISS1 is reported to be involved in the progression of several solid neoplasias, making it a promising molecular target for controlling their metastasis. The KISS1 sequence contains...
8.
Schmitz-Drager B, Kuckuck E, Zuiverloon T, Zwarthoff E, Saltzman A, Srivastava A, et al.
Urol Oncol
. 2016 Sep;
34(10):437-51.
PMID: 27641313
Rationale: Assessment of patients with asymptomatic microhematuria (aMh) has been a challenge to urologists for decades. The aMh is a condition with a high prevalence in the general population and...
9.
Pompas-Veganzones N, Sandonis V, Perez-Lanzac A, Beltran M, Beardo P, Juarez A, et al.
Tumour Biol
. 2016 Sep;
37(10):14301-14310.
PMID: 27592258
Myopodin is a cytoskeleton protein that shuttles to the nucleus depending on the cellular differentiation and stress. It has shown tumor suppressor functions. Myopodin methylation status was useful for staging...
10.
De Faveri L, Hurst C, Roulson J, Wood H, Sanchez-Carbayo M, Knowles M, et al.
Transl Oncol
. 2015 Oct;
8(5):387-399.
PMID: 26500029
Urothelial carcinoma (UC) causes significant morbidity and remains the most expensive cancer to treat because of the need for repeated resections and lifelong monitoring for patients with non-muscle-invasive bladder cancer...